<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <title>About the Author | Depth-First</title>
    <link rel="alternate" href="/articles.atom" title="Depth-First" type="application/atom+xml">
    <link rel="stylesheet" href="/css/reset.css">
    <link rel="stylesheet" href="/css/global.css">
    <link rel="shortcut icon" href="/images/favicon.png">
    <link rel="me" href="https://fosstodon.org/@rapodaca">
        <link rel="stylesheet" href="/css/document.css">
    <link rel="stylesheet" href="/css/page.css">

  </head>
  <body>
    <header>
      <div class="wrapper">
        <div class="site-id"><a href="/">Depth-First</a></div>
        <nav>
          <ul>
            <li><a href="/articles/">Archive</a></li><li><a href="/about/">About</a></li>
          </ul>
        </nav>
      </div>
    </header>
    <main>
      <div class="wrapper">
            <article>
      <header>
        <h1>About the Author</h1>
      </header>
      <p>Richard L. Apodaca is a chemist living in La Jolla, California.</p>
<p>E-mail: <a href="mailto:rich.apodaca@gmail.com">rich.apodaca@gmail.com</a></p>
<p>Online: <a rel="me" href="https://fosstodon.org/@rapodaca">Mastodon</a>; <a href="https://github.com/rapodaca/">GitHub</a>.</p>
<h2 id="educationandwork">Education and Work</h2>
<ul>
<li>Founder at <a href="http://metamolecular.com">Metamolecular, LLC</a></li>
<li>Medicinal Chemist at Johnson &amp; Johnson Pharmaceutical Research &amp; Development (now Janssen Labs at San Diego)</li>
<li>Postdoc, Chemistry at <a href="http://www.stanford.edu/group/bmtrost/">Stanford University</a></li>
<li>Ph.D., Chemistry from <a href="http://www.cm.utexas.edu/">The University of Texas at Austin</a></li>
<li>B.S., Chemistry from <a href="http://chemistry.berkeley.edu/">The University of California at Berkeley</a></li>
</ul>
<h2 id="workingpapers">Working Papers</h2>
<ol>
<li>Apodaca, Richard <a href="https://doi.org/10.26434/chemrxiv-2022-01ltp">Balsa: A Compact Line Notation Based on SMILES</a></li>
</ol>
<h2 id="peerreviewedpublications">Peer-Reviewed Publications</h2>
<ol>
<li>John M. Keith; Mark S. Tichenor; Richard L. Apodaca; Wei Xiao; William M. Jones; Mark Seierstad; Joan M. Pierce; James A.Palmer; Michael Webb; Mark J. Karbarz; Brian P. Scott; Sandy J. Wilson; Michelle L. Wennerholm; Michele Rizzolio; Raymond Rynberg; Sandra R.Chaplan; J. Guy Breitenbucher <a href="http://dx.doi.org/10.1016/j.bmcl.2016.05.001">The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors</a> <em>Bioorg. Med Chem. Lett.</em> <strong>2016</strong>, <em>26</em>, 3109-3114.</li>
<li>Michael A. Letavic; Leah Aluisio; Richard Apodaca; Manoj Bajpai; Ann J. Barbier; Anne Bonneville; Pascal Bonaventure; Nicholas I. Carruthers; Christine Dugovic; Ian C. Fraser; Michelle L. Kramer; Brian Lord; Timothy W. Lovenberg; Lilian Y. Li; Kiev S. Ly; Heather Mcallister; Neelakandha S. Mani; Kirsten L. Morton; Anthony Ndifor; S. Diane Nepomuceno; Chennagiri R. Pandit; Steven B. Sands; Chandra R. Shah; Jonathan E. Shelton; Sandra S. Snook; Devin M. Swanson; and Wei Xiao <a href="http://dx.doi.org/10.1021/ml5005156">Novel Benzamide-Based Histamine H<sub>3</sub> Receptor Antagonists: The Identification of Two Candidates for Clinical Development</a> <em>ACS Med. Chem. Lett.</em> <strong>2015</strong>, <em>6</em>, 450-454.</li>
<li>John M.Keith; Natalie Hawryluk; Richard L. Apodaca; Allison Chambers; Joan M. Pierce; Mark Seierstad; James A. Palmer; Michael Webb; Mark J.Karbarz; Brian P. Scott; Sandy J. Wilson; Lin Luo; Michelle L. Wennerholm; Leon Chang; Michele Rizzolio; Sandra R. Chaplan; J. Guy Breitenbucher <a href="https://doi.org/10.1016/j.bmcl.2014.01.064">1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase</a> <em>Bioorg. Med. Chem. Lett.</em> <strong>2014</strong>, <em>24</em>, 1280-1284.</li>
<li>Williams, Antony K.; Ekins, Sean; Clark, Alex M.; Jack, James; Apodaca, Richard L. <a href="http://dx.doi.org/10.1016/j.drudis.2011.09.002">Mobile apps for chemistry in the world of drug discovery</a> <em>Drug Discovery Today</em> <strong>2011</strong>, <em>16</em>, 928.</li>
<li>Karbarz, M.J.; Luo, L.; Chang, L.; Tham, C-S; Palmer, J.A.; Wilson, S.J.; Wennerholm, M.L.; Brown, S.M.; Scott, B.P.; Apodaca, R.L.; Keith, J.M.; Wu, J.; Breitenbucher, J.G.; Chaplan, S.R.; Webb, M. <a href="http://www.anesthesia-analgesia.org/cgi/content/abstract/108/1/316">Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase</a> <em>Anesth. Analg.</em> <strong>2009</strong>, <em>108</em>, 316-329.</li>
<li>Keith, J.M.; Apodaca, R.; Xiao, W.; Seierstad, M.; Pattabiraman, K.; Wu, J.; Webb, M.; Karbarz, M.J.; Brown, S.; Wilson, S.; Scott, B.; Tham, Cc; Luo, L.; Palmer, J.; Wennerholm, M.; Chaplan, S.; Breitenbucher, J.G. <a href="http://dx.doi.org/10.1016/j.bmcl.2008.07.081">Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase</a> <em>Bioorg. Med. Chem. Lett.</em> <strong>2008</strong>, <em>18</em>, 4838-4843.</li>
<li>Bembenek, S.D.; Keith, J.M.; Letavic, M.A.; Apodaca, R.; Barbier, A.J.; Dvorak, L.; Aluisio, L.; Miller, K.L.; Lovenberg, T.W.; Carruthers, N.I. <a href="http://dx.doi.org/10.1016/j.bmc.2007.12.048">Lead identification of acetylcholinesterase inhibitors–histamine H<sub>3</sub> receptor antagonists from molecular modeling</a> <em>Bioorg. Med. Chem.</em> <strong>2008</strong>, <em>16</em>, 2968-2937.</li>
<li>Timmons, A.; Seierstad, M.; Apodaca, R.; Epperson, M.; Pippel, D.; Brown, S.; Chang, L.; Scott, B.; Webb, M.; Chaplan, S.R.; Breitenbucher, J.G. <a href="http://dx.doi.org/10.1016/j.bmcl.2008.01.091">Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH)</a> <em>Bioorg. Med. Chem. Lett.</em> <strong>2008</strong>, <em>18</em>, 2109-2113.</li>
<li>Romero, F.A.; Du, W.; Hwang, I.; Rayl, T.J.; Kimball, F. S.; Leung, D.; Hoover, H.S.; Apodaca, R.L.; Breitenbucher, J.G.; Cravatt, B.F.; Boger, D. L. <a href="http://dx.doi.org/10.1021/jm0611509">Potent and Selective α-Ketoheterocycle-Based Inhibitors of the Anandamide and Oleamide Catabolizing Enzyme, Fatty Acid Amide Hydrolase</a> <em>J. Med. Chem.</em> <strong>2007</strong>, <em>50</em>, 1058-1068.</li>
<li>Swanson, D.M.; Wilson, S.J.; Boggs, J.D.; Xiao, W.; Apodaca, R.; Barbier, A.J.; Lovenberg, T.W.; Carruthers, N.I. <a href="http://dx.doi.org/10.1016/j.bmcl.2005.11.003">Aplysamine-1 and Related Analogs as Histamine H3 Receptor Antagonists</a>. <em>Bioorg. Med. Chem. Lett.</em> <strong>2006</strong>, <em>16</em>, 897-900.</li>
<li>Dvorak, C. A.; Apodaca, R.; Barbier, A.J.; Berridge, C.W.; Wilson, S.J.; Boggs, J.D.; Xiao, W.; Lovenberg, T.W; Carruthers, N.I. <a href="http://dx.doi.org/10.1021/jm049212n">4-Phenoxypiperidines: Potent, Conformationally Restricted, Non-Imidazole Histamine H3 Antagonists</a>. <em>J. Med. Chem.</em> <strong>2005</strong>, <em>48</em>, 2229-2238.</li>
<li>Barbier, A.J.; Berridge, C.; Dugovic, C.; Laposky, A.D.; Wilson, S.J.; Boggs, J.; Aluisio, L.; Lord, B.; Mazur, C.; Pudiak, C.M.; Langlois, X.; Xiao, W.; Apodaca, R.; Carruthers, N.I.; Lovenberg, T.W. <a href="http://dx.doi.org/10.1038/sj.bjp.0705964">Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist</a>. <em>Br. J. Pharmacol.</em> <strong>2004</strong>, <em>143</em>, 649-661.</li>
<li>Apodaca, Richard; Dvorak, Curt A.; Xiao, Wei; Barbier, Ann J.; Boggs, Jamin D.; Wilson, Sandy J.; Lovenberg, Timothy W.; Carruthers, Nicholas I.  <a href="http://dx.doi.org/10.1021/jm030185v">A New Class of Diamine-Based Human Histamine H3 Receptor Antagonists: 4-(Aminoalkoxy)benzylamines</a>. <em>J. Med. Chem.</em> <strong>2003</strong>, <em>46</em>, 3938-3944.</li>
<li>Apodaca, R.; Xiao, W. <a href="http://dx.doi.org/10.1021/ol015948s">Direct Reductive Amination of Aldehydes and Ketones: Catalysis by Dibutyltin Dichloride</a>. <em>Org. Lett.</em> <strong>2001</strong>, <em>3</em>, 1745-1748.</li>
<li>Lynch, Vincent M.; Apodaca, Richard; Whitesell, James K.; Chou, Ming I.  <a href="http://dx.doi.org/10.1107/S0108270198099296">Trans-(R,R)-2,2'-(cyclopenta-1,2-diyl)diphenyl bis[(R)-O-methylmandelate]</a>. <em>Acta Crystallographica, Section C: Crystal Structure Communications</em> <strong>1998</strong>, <em>10</em>, C54.</li>
<li>Apodaca R.  <a href="http://dx.doi.org/10.1021/ja965708l">Comprehensive Organic Functional Group Transformations. (Book Review)</a> <em>J. Am. Chem Soc.</em> <strong>1997</strong>, <em>119</em>, 2343.</li>
<li>Whitesell, J.K.; Apodaca, R.  <a href="http://dx.doi.org/10.1016/S0040-4039(97)00421-8">Synthesis and Resolution of a New Chiral C2‑Symmetrical Bisphenol:  trans-1,2-Bis(2-hydroxyphenyl)cyclopentane</a>. <em>Tetrahedron Lett.</em> <strong>1997</strong>, <em>38</em>, 2589-2592.</li>
<li>Whitesell, J.K.; Apodaca, R.  <a href="http://dx.doi.org/10.1016/0040-4039(96)00719-8">A Convenient Synthesis of Protected and Free Homallylic Alcohols:  Catalytic Use of Dibutyltin Dichloride in the Allylation of Aldehydes with Allyltributyltin</a>. <em>Tetrahedron Lett.</em> <strong>1996</strong>, <em>37</em>, 3955-3958.</li>
<li>Whitesell, J.K.; Apodaca, R. <a href="http://dx.doi.org/10.1016/0040-4039(96)00386-3">Trimethylsilylcyanation of Aldehydes and Ketones Catalyzed by Diorganotin Dichlorides</a>.  <em>Tetrahedron Lett.</em> <strong>1996</strong>, <em>37</em>, 2525-2528.</li>
</ol>
<h2 id="issuedpatents">Issued Patents</h2>
<ol>
<li>Richard Apodaca, J. Guy Breitenbucher, Kanaka Pattabiraman, Mark Seierstad, Wei Xiao <em>Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase</em> <a href="https://patents.google.com/patent/US9169224B2/en">US 9,169,224</a></li>
<li>Natalie A. Hawryluk J. Guy Breitenbucher William M. Jones Alison L. Chambers John M. Keith Mark Seierstad <em>Ethylene diamine modulators of fatty acid hydrolase</em> <a href="https://patents.google.com/patent/US8906914B2/en">US 8,906,914</a></li>
<li>Richard Apodaca, J. Guy Breitenbucher, Alison L. Chambers, Xiaohu Deng, Natalie A. Hawryluk, John M. Keith, Neelakandha S. Mani, Jeffrey E. Merit, Joan M. Pierce, Mark Seierstad, Wei Xiao <em>Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase</em> <a href="https://patents.google.com/patent/US8598202B2/en">US 8,598,202</a></li>
<li>Richard Apodaca, J. Guy Breitenbucher, Kanaka Pattabiraman, Mark Seierstad, Wei Xiao <em>Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase</em> <a href="https://patents.google.com/patent/US8530476B2/en">US 8,530,476</a></li>
<li>Apodaca; Richard, Barbier; Ann J.; Carruthers; Nicholas I.; Gomez; Leslie A.; Keith; John M., Lovenberg; Timothy W., Wolin; Ronald L. <em>Hexahydro-pyrrolo-isoquinoline compounds</em> <a href="https://patents.google.com/patent/US8273762B2/">US 8,273,762</a></li>
<li>Apodaca; Richard, Barbier; Ann J., Carruthers; Nicholas I., Gomez; Leslie A., Keith; John M., Lovenberg; Timothy W., Wolin; Ronald L. <em>Hexahydro-pyrrolo-isoquinoline compounds</em> <a href="https://patents.google.com/patent/US7754882B2/">US 7,754,882</a></li>
<li>Apodaca; Richard, Breitenbucher; J. Guy, Pattabiraman; Kanaka, Seierstad; Mark, Xiao; Wei <em>Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase</em> <a href="https://patents.google.com/patent/US7598249B2/">US 7,598,249</a></li>
<li>Apodaca; Richard, Breitenbucher; J. Guy, Pattabiraman; Kanaka, Seierstad; Mark, Xiao; Wei <em>N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase</em>  <a href="https://patents.google.com/patent/US7541359B2/">US 7,541,359</a></li>
<li>Apodaca; Richard, Deng; Xiaohu, Jablonowski; Jill A., Mani; Neelakandha, Pandit; Chennagiri R., Xiao; Wei <em>Phenylalkynes</em> <a href="https://patents.google.com/patent/US7482364B2/">US 7,482,364</a></li>
<li>Apodaca; Richard, Deng; Xiaohu, Jablonowski; Jill A., Mani; Neelakandha, Pandit; Chennagiri R., Xiao; Wei <em>Phenylalkynes</em> <a href="https://patents.google.com/patent/US7446104B2/">US 7,446,104</a></li>
<li>Apodaca; Richard, Carruthers; Nicholas I., Dvorak; Curt A., Rudolph; Dale A., Shah; Chandravadan R., Xiao; Wei <em>Non-imidazole aryloxyalkylamines</em> <a href="https://patents.google.com/patent/US7429586B2/">US 7,429,586</a></li>
<li>Apodaca; Richard L., Jablonowski; Jill A., Ly; Kiev S., Shah; Chandravadan R., Swanson; Devin M., Xiao; Wei <em>Piperazinyl and diazapanyl benzamides and benzthioamides</em> <a href="https://patents.google.com/patent/US7414047B2/">US 7,414,047</a></li>
<li>Apodaca; Richard, Deng; Xiaohu, Jablonowski; Jill A., Mani; Neelakandha, Pandit; Chennagiri R., Xiao; Wei <em>Phenylalkynes</em> <a href="https://patents.google.com/patent/US7288540B2/">US 7,288,540</a></li>
<li>Apodaca; Richard L., Dvorak; Curt A., Shah; Chandravadan R., Xiao; Wei <em>Phenylpiperidines and phenylpyrrolidines</em> <a href="https://patents.google.com/patent/US7279491B2/">US 7,279,491</a></li>
<li>Apodaca; Richard, Carruthers; Nicholas I., Dvorak; Curt A., Shah; Chandravadan R., Xiao; Wei <em>Non-imidazole aryloxypiperidines</em> <a href="https://patents.google.com/patent/US7241778B2/">US 7,241,778</a></li>
<li>Apodaca; Richard, Carruthers; Nicholas I., Dvorak; Curt A., Rudolph; Dale A., Shah; Chandravadan R., Xiao; Wei <em>Non-imidazole aryloxyalkylamines</em> <a href="https://patents.google.com/patent/US7186732B2/">US 7,186,732</a></li>
<li>Apodaca; Richard, Carruthers; Nicholas I., Dvorak; Curt A., Shah; Chandravadan R., Xiao; Wei <em>Non-imidazole aryloxypiperidines</em> <a href="https://patents.google.com/patent/US7071191B2/">US 7,071,191</a></li>
<li>Apodaca; Richard, Xiao; Wei, Jablonowski; Jill A. <em>Phenylalkynes</em> <a href="https://patents.google.com/patent/US6884803B2/">US 6,884,803</a></li>
</ol>
<h2 id="patentapplications">Patent Applications</h2>
<ol>
<li>Apodaca, Richard; Barbier, Ann J.; Carruthers, Nicholas I.; Gomez, Leslie A.; Keith, John M.; Lovenberg, Timothy W.; Wolin, Ronald L. <em>Hexahydro-pyrrolo-isoquinoline Compounds</em> US 20120321559</li>
<li>Apodaca, Richard; Breitenbucher, J., Guy; Chambers, Alison, L.; Deng, Xiaohu; Hawryluk, Natalie, A.; Keith, John, M.; Mani, Neelakandha, S.; Merit, Jeffrey, E.; Pierce, Joan, M.; Seierstad, Mark; Xiao, Wei <em>Aryl - Hydroxyethylamino - Pyrimidines and Triazines as Modulators of Fatty Acid amide Hydrolase.</em> WO 2009/105220</li>
<li>Apodaca, Richard; Breitenbucher, J., Guy; Hawryluk, Natalie, A.; Jones, William, M.; Keith, John, M.; Merit, Jeffrey, E.;  Tichenor, Mark, S.; Timmons, Amy, K. <em>Heteroaryl-Substituted Urea Modulators of Fatty Acid Amide Hydrolase.</em> WO 2008153752</li>
<li>Apodaca, Richard; Breitenbucher, J. Guy; Pattabiraman, Kanaka; Seierstad, Mark; Xiao, Wei. <em>Preparation of thiadiazolylpiperazinecarboxamides as modulators of fatty acid amide hydrolase (FAAH).</em> US 2007004741</li>
<li>Apodaca, Richard; Breitenbucher, James, Guy; Chambers, Alison L.; Seierstad, Mark; Xiao, Wei <em>Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase</em> WO 2007140005</li>
<li>Apodaca, Richard; Breitenbucher, J., Guy; Epperson, Matthew, T.; Fried, Amy, K.; Pippel, Daniel, J.; Seierstad, Mark <em>2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase</em> WO 2007061862</li>
<li>Apodaca, Richard; Breitenbucher, J., Guy; Pattabiraman, Kanaka;  Seierstad, Mark; Xiao, Wei <em>N-Heteroarylpiperazinly Ureas as Modulators of Fatty Acid Amide Hydrolase</em> WO 2007005510</li>
<li>Apodaca, Richard; Barbier, Ann J.; Carruthers, Nicholas I.; Gomez, Leslie A.; Keith, John M.; Lovenberg, Timothy W.; Wolin, Ronald L. <em>Hexahydropyrroloisoquinoline compounds as histamine H3 receptor and serotonin transporter modulators and their preparation, pharmaceutical compositions and use in the treatment of CNS disorders</em> WO 2006138604</li>
<li>Apodaca, Richard; Breitenbucher, J. Guy; Pattabiraman, Kanaka; Seierstad, Mark; Xiao, Wei. <em>Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase</em> WO 2006074025</li>
<li>Apodaca, Richard L.; Dvorak, Curt A.; Shah, Chandravadan R.; Xiao, Wei.   <em>Preparation of phenylpiperidines and phenylpyrrolidines as histamine H3 receptor inhibitors</em> US  2004087573</li>
<li>Apodaca, Richard L.; Jablonowski, Jill A.; Ly, Kiev S.; Shah, Chandravadan R.; Swanson, Devin M.; Xiao, Wei.   <em>Preparation of piperazinyl and diazepanyl benzamides and benzothioamides as inhibitors of histamine H3 receptor</em> WO  2004037801</li>
<li>Apodaca, Richard L.; Dvorak, Curt A.; Shah, Chandravadan R.; Xiao, Wei. <em>Preparation of phenylpiperidines and phenylpyrrolidines as histamine H3 receptor modulators</em> WO  2004037257</li>
<li>Apodaca, Richard; Deng, Xiaohu; Jablonowski, Jill A.; Mani, Neelakandha; Pandit, Chennagiri R.; Xiao, Wei. <em>Preparation of substituted phenylalkynes as H3 receptor ligands</em> US  2004002604</li>
<li>Apodaca, Richard; Xiao, Wei; Jablonoski, Jill A.   <em>Preparation of substituted phenylalkynes for use in histamine-mediated disorders</em> 2003050099</li>
<li>Apodaca, Richard; Carruthers, Nicholas I.; Carson, John R.; Chai, Wenying; Kwok, Annette K.; Li, Xiaobing; Lovenberg, Timothy W.; Rudolph, Dale A.; Shah, Chandravadan R.   <em>Octahydroindolizine and quinolizine and hexahydropyrrolizine derivatives as histaminic H1 and H3 antagonists</em> WO 2002024695</li>
<li>Apodaca, Richard; Carruthers, Nicholas I.; Dvorak, Curt A.; Rudolph, Dale A.; Shah, Chandravadan R.; Xiao, Wei.   <em>Preparation of non-imidazole aryloxyalkylamines as histamine H3 receptor antagonists.</em> WO 2002012214</li>
<li>Apodaca, Richard; Carruthers, Nicholas I.; Dvorak, Curt A.; Shah, Chandravadan R.; Xiao, Wei. <em>Preparation of aryloxypiperidines as histamine H3 receptor antagonists</em> WO  2002012190</li>
</ol>
    </article>

      </div>
    </main>
    <footer>
      <ul>
        <li>&copy; 2006-2024<li><a href="https://creativecommons.org/licenses/by/2.0/">CC-BY</a></li><li><a href="/about/">Richard L. Apodaca</a></li><li><a href="/articles.atom">Feed</a></li>
      </ul>
    </footer>
    <script src="/js/moment.js"></script>
    <script src="/js/timestamps.js"></script>
    <script src="/js/analytics.js"></script>
  </body>
</html>